Your browser doesn't support javascript.
loading
Looking ahead and behind at supplemental oxygen: A qualitative study of patients with pulmonary fibrosis.
Graney, Bridget A; Wamboldt, Frederick S; Baird, Susan; Churney, Tara; Fier, Kaitlin; Korn, Marjorie; McCormick, Mark; Vierzba, Thomas; Swigris, Jeffrey J.
Afiliação
  • Graney BA; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA.
  • Wamboldt FS; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA; Division of Pulmonary, Critical Care and Sleep Medicine, Sleep & Behavioral Health Sciences Section, National Jewish Health, Denver, CO, USA.
  • Baird S; Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, Office #G011 1400 Jackson Street, Denver, CO 80206, USA.
  • Churney T; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA; Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, Office #G011 1400 Jackson Street, Denver, CO 80206, USA.
  • Fier K; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA; Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, Office #G011 1400 Jackson Street, Denver, CO 80206, USA.
  • Korn M; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA.
  • McCormick M; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA.
  • Vierzba T; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA.
  • Swigris JJ; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Participation Program for Pulmonary Fibrosis (P3F), Denver, CO, USA; Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, O
Heart Lung ; 46(5): 387-393, 2017.
Article em En | MEDLINE | ID: mdl-28774655
ABSTRACT
RATIONALE Supplemental oxygen is prescribed to patients with pulmonary fibrosis to normalize oxygen saturations, decrease symptoms and improve quality of life. Along with potential benefits, patients face challenges as they incorporate oxygen into their lives.

OBJECTIVE:

Our aim was to better understand the perceptions and experiences of patients with pulmonary fibrosis as they confronted the possibility and realities of using supplemental oxygen.

METHODS:

We performed a mixed-methods study in which we conducted a series of four structured telephone interviews with five patients with pulmonary fibrosis enrolled in a longitudinal observational study. Questionnaires were administered at the time of the interviews, which were conducted at enrollment in the longitudinal study, immediately prior to starting supplemental oxygen, one month and then 9-12 months after starting oxygen. We used conventional content analysis to analyze interview data for themes within and across the four time points.

RESULTS:

Prior to starting supplemental oxygen, participants uniformly expected it would improve their physical function and quality of life. They also expected practical and psychological limitations, which after starting oxygen, they found to be more pronounced than anticipated. Despite the challenges, participants attributed benefits in symptoms, confidence and mobility to oxygen and came to a reluctant acceptance of it. Their expectations for guidance and support were inadequately met.

CONCLUSIONS:

For patients with pulmonary fibrosis, starting and using supplemental oxygen on an everyday basis confers benefits while also presenting a significant number of challenges. The process could be improved by providing them with clearer expectations and trustworthy educational resources. Oxygen case managers could help patients incorporate supplemental oxygen more seamlessly into their lives.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigênio / Oxigenoterapia / Fibrose Pulmonar / Qualidade de Vida / Pesquisa Qualitativa Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Lung Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigênio / Oxigenoterapia / Fibrose Pulmonar / Qualidade de Vida / Pesquisa Qualitativa Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Lung Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos